These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 23785274
1. Impact of ribosomal modification on the binding of the antibiotic telithromycin using a combined grand canonical monte carlo/molecular dynamics simulation approach. Small MC, Lopes P, Andrade RB, Mackerell AD. PLoS Comput Biol; 2013; 9(6):e1003113. PubMed ID: 23785274 [Abstract] [Full Text] [Related]
2. Binding site of the bridged macrolides in the Escherichia coli ribosome. Xiong L, Korkhin Y, Mankin AS. Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307 [Abstract] [Full Text] [Related]
3. Induction of erm(C) expression by noninducing antibiotics. Bailey M, Chettiath T, Mankin AS. Antimicrob Agents Chemother; 2008 Mar; 52(3):866-74. PubMed ID: 18086834 [Abstract] [Full Text] [Related]
4. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study. Nguyen HL, An PH, Thai NQ, Linh HQ, Li MS. J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217 [Abstract] [Full Text] [Related]
5. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. Novotny GW, Jakobsen L, Andersen NM, Poehlsgaard J, Douthwaite S. Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419 [Abstract] [Full Text] [Related]
6. Investigating the entire course of telithromycin binding to Escherichia coli ribosomes. Kostopoulou ON, Petropoulos AD, Dinos GP, Choli-Papadopoulou T, Kalpaxis DL. Nucleic Acids Res; 2012 Jun; 40(11):5078-87. PubMed ID: 22362747 [Abstract] [Full Text] [Related]
7. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. Llano-Sotelo B, Dunkle J, Klepacki D, Zhang W, Fernandes P, Cate JH, Mankin AS. Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725 [Abstract] [Full Text] [Related]
8. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. Garza-Ramos G, Xiong L, Zhong P, Mankin A. J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379 [Abstract] [Full Text] [Related]
9. Enhancing sampling of water rehydration upon ligand binding using variants of grand canonical Monte Carlo. Ge Y, Melling OJ, Dong W, Essex JW, Mobley DL. J Comput Aided Mol Des; 2022 Oct; 36(10):767-779. PubMed ID: 36198874 [Abstract] [Full Text] [Related]
10. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm. Douthwaite S, Jalava J, Jakobsen L. Mol Microbiol; 2005 Oct; 58(2):613-22. PubMed ID: 16194243 [Abstract] [Full Text] [Related]
11. Toward the rational design of macrolide antibiotics to combat resistance. Pavlova A, Parks JM, Oyelere AK, Gumbart JC. Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786 [Abstract] [Full Text] [Related]
12. RlmCD-mediated U747 methylation promotes efficient G748 methylation by methyltransferase RlmAII in 23S rRNA in Streptococcus pneumoniae; interplay between two rRNA methylations responsible for telithromycin susceptibility. Shoji T, Takaya A, Sato Y, Kimura S, Suzuki T, Yamamoto T. Nucleic Acids Res; 2015 Oct 15; 43(18):8964-72. PubMed ID: 26365244 [Abstract] [Full Text] [Related]
13. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. Zhanel GG, Hartel E, Adam H, Zelenitsky S, Zhanel MA, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty AJ, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA. Drugs; 2016 Dec 15; 76(18):1737-1757. PubMed ID: 27909995 [Abstract] [Full Text] [Related]
14. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. Xiong L, Shah S, Mauvais P, Mankin AS. Mol Microbiol; 1999 Jan 15; 31(2):633-9. PubMed ID: 10027979 [Abstract] [Full Text] [Related]
15. Molecular dynamics simulations suggest why the A2058G mutation in 23S RNA results in bacterial resistance against clindamycin. Kulczycka-Mierzejewska K, Sadlej J, Trylska J. J Mol Model; 2018 Jul 03; 24(8):191. PubMed ID: 29971530 [Abstract] [Full Text] [Related]
16. Telithromycin: the first of the ketolides. Shain CS, Amsden GW. Ann Pharmacother; 2002 Mar 03; 36(3):452-64. PubMed ID: 11895060 [Abstract] [Full Text] [Related]
17. 23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22. Berisio R, Corti N, Pfister P, Yonath A, Böttger EC. Antimicrob Agents Chemother; 2006 Nov 03; 50(11):3816-23. PubMed ID: 16923950 [Abstract] [Full Text] [Related]
18. Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation. Wolter N, Smith AM, Farrell DJ, Northwood JB, Douthwaite S, Klugman KP. Antimicrob Agents Chemother; 2008 Feb 03; 52(2):435-40. PubMed ID: 18056269 [Abstract] [Full Text] [Related]
19. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Tu D, Blaha G, Moore PB, Steitz TA. Cell; 2005 Apr 22; 121(2):257-70. PubMed ID: 15851032 [Abstract] [Full Text] [Related]
20. Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci. Shortridge VD, Zhong P, Cao Z, Beyer JM, Almer LS, Ramer NC, Doktor SZ, Flamm RK. Antimicrob Agents Chemother; 2002 Mar 22; 46(3):783-6. PubMed ID: 11850262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]